TEST BANK
Abrams' Clinical Drug Therapy: Rationales for Nursing Practice by Geralyn
Frandsen, and Sandra Smith Pennington
f
,Table of Contents
Chapter 01 The Foundation of PharmacologyQuality and Safety 1
Chapter 02 Basic Concepts and Processes 11
Chapter 03 Medication Administration and the Nursing Process of Drug Therapy 20
Chapter 04 Pharmacology and the Care of Infants and Pediatric Patients 29
Chapter 05 Pharmacology and the Care of Adults and Geriatric Patients 40
Chapter 06 Pharmacology and the Care of Pregnant or Lactating Fern ales 51
Chapter O7 Pharmacology and Female Health 61
Chapter 08 Pharmacology and Male Health 71
Chapter 09 Drug Therapy for Coagulation Disorders 83
Chapter 10 Drug Therapy for Dyslipidemia 93
Chapter 11 Drug Therapy for Hematopoietic Disorders 103
Chapter 12 Drug Therapy Immunizations 113
Chapter 13 Drug Therapy to Decrease Immunity 123
Chapter 14 Drug Therapy for the T re.atrnent of Cancer 134
Chapter 15 Inflainmation, Infection, and the Use of Antibacterial Agents 144
Chapter 16 Drug Therapy to Decrease Pain, F ever and Inflainmation 155
Chapter 17 Drug Therapy with Corticosteroids 165
Chapter 18 Drug Therapy \Vith BetaLactain Antibacterial Agents 176
Chapter 19 Drug Therapy \Vith Aminoglycosides a,1d Fluoroquinolones 186
Chapter 20 Drug Therapy \Vith Tetracyclines, Sulfonainides, a,1d Urinary Antiseptics 197
Chapter 21 Drug Therapy \Vith Macrolides a,1d l\1iscellaneous Anti-Infecti\ e Agents 208
Chapter 22 Drug Therapy for Tuberculosis and Mycobacterium avium Co,nplex Disease 218
Chapter 23 Drug Therapy for Viral Infections 228
Chapter 24 Drug Therapy for Fungal Infections 239
Chapter 25 Drug Therapy for Parasitic Infections 249
Chapter 26 Drug Therapy for Hypertension 260
Chapter 27 Drug Therapy for Dysrhy1hmias 270
Chapter 28 Drug Therapy for Coronary Heart Disease 280
Chapter 29 Drug Therapy for Shock and Hypotension 290
Chapter 30 Drug Therapy for Heart Failure 300
Chapter 31 Drug Therapy for Nasal Congestion and Cough 310
Chapter 32 Drug Therapy to Decrease Histainine Effects and Allergie Response 321
Chapter 33 Drug Therapy for Asthma, Ainvay Inflain1nation, and Bronchoconstriction 331
Chapter 34 Drug Therapy for Fluid Volume Excess 342
Chapter 35 Nutritional Support Products, Vitainins, and Minerai Supplements 353
Chapter 36 Drug Therapy for \Veight Mai1agement 363
Chapter 37 Drugs Therapy for Peptic Ulcer Disease and Hyperacidity 373
Chapter 38 Drug Therapy for Nausea and Vomiting 383
Chapter 39 Drug Therapy for Constipation and Eli1nination Problems 393
Chapter 40 Drug Therapy for Diarrhea 403
Chapter 41 Drug Therapy for Diabetes Mellitus 413
f
,Chapter 40: Drug Therapy for Diarrhea............................................................................................................ 403
Chapter 41: Drug Therapy for Diabetes Mellitus ............................................................................................. 413
Chapter 42: Drug Therapy for Hyperthyroidism and Hypothyroidism ............................................................ 423
Chapter 43: Drug Therapy for Pituitary and Hypothalamic Dysfunction......................................................... 433
Chapter 44: Drug Therapy to Regulate Calcium and Bone Metabolism .......................................................... 443
Chapter 45: Drug Therapy for Adrenal Cortex Disorders ................................................................................ 453
Chapter 46: Physiology of the Autonomic and Central Nervous Systems and Indications for the Use of Drug Therapy 463
Chapter 47: Drug Therapy for Myasthenia Gravis, Alzheimer Disease, and Urinary Retention ..................... 475
Chapter 48: Drug Therapy for Parkinson Disease, Urinary Spasticity, and Disorders Requiring Anticholinergic Drug
Therapy ............................................................................................................................................................................. 486
Chapter 49: Drug Therapy With Opioids.......................................................................................................... 496
Chapter 50: Drug Therapy With Local Anesthetics ......................................................................................... 506
Chapter 51: Drug Therapy With General Anesthetics ...................................................................................... 514
Chapter 52: Drug Therapy for Migraines and other Headaches ....................................................................... 523
Chapter 53: Drug Therapy for Seizure Disorders and Skeletal Muscle Relaxants ........................................... 532
Chapter 54: Drug Therapy for Anxiety and Insomnia ...................................................................................... 541
Chapter 55: Antidespressants and Mood Stabilizers ........................................................................................ 551
Chapter 56: Drug Therapy for Psychotic Disorders ......................................................................................... 560
Chapter 57: Drug Therapy for Attention Deficit Hyperactivity Disorder and Narcolepsy .............................. 569
Chapter 58: Drug Therapy for Substance Use Disorders.................................................................................. 578
Chapter 59: Drug Therapy for Disorders of the Eye......................................................................................... 586
Chapter 60: Drug Therapy for Disorders of the Ear ......................................................................................... 594
Chapter 61: Drug Therapy for Disorders of the Skin ....................................................................................... 602
f
, Chapter 1: The Foundation of Pharmacology: Quality and Safety
1. A woman diagnosed with obsessive–compulsive disorder has been prescribed oral
paroxetine hydrochloride. What is the expected effect for this prescription?
A. Curative effect on symptoms
B. Systemic effect on symptoms
C. Local effect on symptoms
D. Parenteral effect on symptoms
ANS: B
Rationale: Drugs that produce systemic effects are taken into the body, circulated through
the bloodstream to their sites of action in various body tissues, and eventually eliminated
from the body. Curative agents are given to cure a disease process. In this case, paroxetine
hydrochloride will control the symptoms but not cure the disorder. Drugs with local
effects, such as sunscreen and local anesthetics, act mainly at the site of application.
Paroxetine hydrochloride is not administered parenterally. Parenteral agents are
administered subcutaneously, intramuscularly, or intravenously.
PTS: 1 REF: p. 4 OBJ: 1
NAT: Client Needs: Physiological Integrity: Pharmacological and Parenteral Therapies
TOP: Chapter 1: The Foundation of Pharmacology: Quality and Safety
KEY: Integrated Process: Nursing Process BLM: Cognitive Level:
Understand
NOT: Multiple Choice
2. A client has been prescribed an antibiotic. This medication is a naturally occurring
substance that has been chemically modified. What is another name for this type of
medication?
A. Synthetic drug
B. Semisynthetic drug
C. Biotechnology drug
D. Prototype drug
ANS: B
Rationale: Semisynthetic drugs (e.g., many antibiotics) are naturally occurring substances
that have been chemically modified. Synthetic drugs are more standardized in their
chemical characteristics, more consistent in their effects, and less likely to produce allergic
reactions. Biotechnology drugs involve manipulating DNA and RNA and recombining
genes into hybrid molecules that can be inserted into living organisms. Prototype drugs are
the first drug of a particular group to be developed.
PTS: 1 REF: p. 4 OBJ: 1
NAT: Client Needs: Physiological Integrity: Pharmacological and Parenteral Therapies
TOP: Chapter 1: The Foundation of Pharmacology: Quality and Safety
KEY: Integrated Process: Nursing Process BLM: Cognitive Level:
Understand
NOT: Multiple Choice
3. Which classification applies to morphine?
A. Central nervous system depressant
1|Page
f
Abrams' Clinical Drug Therapy: Rationales for Nursing Practice by Geralyn
Frandsen, and Sandra Smith Pennington
f
,Table of Contents
Chapter 01 The Foundation of PharmacologyQuality and Safety 1
Chapter 02 Basic Concepts and Processes 11
Chapter 03 Medication Administration and the Nursing Process of Drug Therapy 20
Chapter 04 Pharmacology and the Care of Infants and Pediatric Patients 29
Chapter 05 Pharmacology and the Care of Adults and Geriatric Patients 40
Chapter 06 Pharmacology and the Care of Pregnant or Lactating Fern ales 51
Chapter O7 Pharmacology and Female Health 61
Chapter 08 Pharmacology and Male Health 71
Chapter 09 Drug Therapy for Coagulation Disorders 83
Chapter 10 Drug Therapy for Dyslipidemia 93
Chapter 11 Drug Therapy for Hematopoietic Disorders 103
Chapter 12 Drug Therapy Immunizations 113
Chapter 13 Drug Therapy to Decrease Immunity 123
Chapter 14 Drug Therapy for the T re.atrnent of Cancer 134
Chapter 15 Inflainmation, Infection, and the Use of Antibacterial Agents 144
Chapter 16 Drug Therapy to Decrease Pain, F ever and Inflainmation 155
Chapter 17 Drug Therapy with Corticosteroids 165
Chapter 18 Drug Therapy \Vith BetaLactain Antibacterial Agents 176
Chapter 19 Drug Therapy \Vith Aminoglycosides a,1d Fluoroquinolones 186
Chapter 20 Drug Therapy \Vith Tetracyclines, Sulfonainides, a,1d Urinary Antiseptics 197
Chapter 21 Drug Therapy \Vith Macrolides a,1d l\1iscellaneous Anti-Infecti\ e Agents 208
Chapter 22 Drug Therapy for Tuberculosis and Mycobacterium avium Co,nplex Disease 218
Chapter 23 Drug Therapy for Viral Infections 228
Chapter 24 Drug Therapy for Fungal Infections 239
Chapter 25 Drug Therapy for Parasitic Infections 249
Chapter 26 Drug Therapy for Hypertension 260
Chapter 27 Drug Therapy for Dysrhy1hmias 270
Chapter 28 Drug Therapy for Coronary Heart Disease 280
Chapter 29 Drug Therapy for Shock and Hypotension 290
Chapter 30 Drug Therapy for Heart Failure 300
Chapter 31 Drug Therapy for Nasal Congestion and Cough 310
Chapter 32 Drug Therapy to Decrease Histainine Effects and Allergie Response 321
Chapter 33 Drug Therapy for Asthma, Ainvay Inflain1nation, and Bronchoconstriction 331
Chapter 34 Drug Therapy for Fluid Volume Excess 342
Chapter 35 Nutritional Support Products, Vitainins, and Minerai Supplements 353
Chapter 36 Drug Therapy for \Veight Mai1agement 363
Chapter 37 Drugs Therapy for Peptic Ulcer Disease and Hyperacidity 373
Chapter 38 Drug Therapy for Nausea and Vomiting 383
Chapter 39 Drug Therapy for Constipation and Eli1nination Problems 393
Chapter 40 Drug Therapy for Diarrhea 403
Chapter 41 Drug Therapy for Diabetes Mellitus 413
f
,Chapter 40: Drug Therapy for Diarrhea............................................................................................................ 403
Chapter 41: Drug Therapy for Diabetes Mellitus ............................................................................................. 413
Chapter 42: Drug Therapy for Hyperthyroidism and Hypothyroidism ............................................................ 423
Chapter 43: Drug Therapy for Pituitary and Hypothalamic Dysfunction......................................................... 433
Chapter 44: Drug Therapy to Regulate Calcium and Bone Metabolism .......................................................... 443
Chapter 45: Drug Therapy for Adrenal Cortex Disorders ................................................................................ 453
Chapter 46: Physiology of the Autonomic and Central Nervous Systems and Indications for the Use of Drug Therapy 463
Chapter 47: Drug Therapy for Myasthenia Gravis, Alzheimer Disease, and Urinary Retention ..................... 475
Chapter 48: Drug Therapy for Parkinson Disease, Urinary Spasticity, and Disorders Requiring Anticholinergic Drug
Therapy ............................................................................................................................................................................. 486
Chapter 49: Drug Therapy With Opioids.......................................................................................................... 496
Chapter 50: Drug Therapy With Local Anesthetics ......................................................................................... 506
Chapter 51: Drug Therapy With General Anesthetics ...................................................................................... 514
Chapter 52: Drug Therapy for Migraines and other Headaches ....................................................................... 523
Chapter 53: Drug Therapy for Seizure Disorders and Skeletal Muscle Relaxants ........................................... 532
Chapter 54: Drug Therapy for Anxiety and Insomnia ...................................................................................... 541
Chapter 55: Antidespressants and Mood Stabilizers ........................................................................................ 551
Chapter 56: Drug Therapy for Psychotic Disorders ......................................................................................... 560
Chapter 57: Drug Therapy for Attention Deficit Hyperactivity Disorder and Narcolepsy .............................. 569
Chapter 58: Drug Therapy for Substance Use Disorders.................................................................................. 578
Chapter 59: Drug Therapy for Disorders of the Eye......................................................................................... 586
Chapter 60: Drug Therapy for Disorders of the Ear ......................................................................................... 594
Chapter 61: Drug Therapy for Disorders of the Skin ....................................................................................... 602
f
, Chapter 1: The Foundation of Pharmacology: Quality and Safety
1. A woman diagnosed with obsessive–compulsive disorder has been prescribed oral
paroxetine hydrochloride. What is the expected effect for this prescription?
A. Curative effect on symptoms
B. Systemic effect on symptoms
C. Local effect on symptoms
D. Parenteral effect on symptoms
ANS: B
Rationale: Drugs that produce systemic effects are taken into the body, circulated through
the bloodstream to their sites of action in various body tissues, and eventually eliminated
from the body. Curative agents are given to cure a disease process. In this case, paroxetine
hydrochloride will control the symptoms but not cure the disorder. Drugs with local
effects, such as sunscreen and local anesthetics, act mainly at the site of application.
Paroxetine hydrochloride is not administered parenterally. Parenteral agents are
administered subcutaneously, intramuscularly, or intravenously.
PTS: 1 REF: p. 4 OBJ: 1
NAT: Client Needs: Physiological Integrity: Pharmacological and Parenteral Therapies
TOP: Chapter 1: The Foundation of Pharmacology: Quality and Safety
KEY: Integrated Process: Nursing Process BLM: Cognitive Level:
Understand
NOT: Multiple Choice
2. A client has been prescribed an antibiotic. This medication is a naturally occurring
substance that has been chemically modified. What is another name for this type of
medication?
A. Synthetic drug
B. Semisynthetic drug
C. Biotechnology drug
D. Prototype drug
ANS: B
Rationale: Semisynthetic drugs (e.g., many antibiotics) are naturally occurring substances
that have been chemically modified. Synthetic drugs are more standardized in their
chemical characteristics, more consistent in their effects, and less likely to produce allergic
reactions. Biotechnology drugs involve manipulating DNA and RNA and recombining
genes into hybrid molecules that can be inserted into living organisms. Prototype drugs are
the first drug of a particular group to be developed.
PTS: 1 REF: p. 4 OBJ: 1
NAT: Client Needs: Physiological Integrity: Pharmacological and Parenteral Therapies
TOP: Chapter 1: The Foundation of Pharmacology: Quality and Safety
KEY: Integrated Process: Nursing Process BLM: Cognitive Level:
Understand
NOT: Multiple Choice
3. Which classification applies to morphine?
A. Central nervous system depressant
1|Page
f
